Epilepsy in pregnancy

Clinical Obstetrics and Gynecology

Volumn 56, Issue 2, 2013, Pages 330-341

  Kamyar, Manijeh ^a   Varner, Michael ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptic drugs; Epilepsy; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TOPIRAMATE; VALPROIC ACID;

ARTICLE; CLEFT FACE; CLEFT LIP PALATE; COMORBIDITY; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DELIVERY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG METABOLISM; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; HYPOSPADIAS; INTRAUTERINE GROWTH RETARDATION; LABOR; MIGRAINE; MONOTHERAPY; NEURAL TUBE DEFECT; PATIENT COUNSELING; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; SKELETON MALFORMATION; SLEEP DISORDER;

ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE;

EID: 84877582932     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31828f2436     Document Type: Article

References (47)

1. Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the "common" neurologic disorders? Neurology. 2007;68:326-337.
2. Daroff RB, Fenichel GM, Jankovic J, et al. Bradley's Neurology in Clinical Practice. 6th ed. Philadephia: Elsevier Saunder; 2012: 1583-1630 Chapter 67, Epilepsies.
3. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005- 2009. Epilepsia. 2010;51:676-685.
4. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl JMed. 2000;342:314-319.
5. Kossoff EH, Andermann F. Migraine and epilepsy. Semin Pediatr Neurol. 2010;17:117-122.
6. Malow BA, Levy K, Maturen K, et al. Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology. 2000;55: 1002-1007.
7. Tomson T, Walczak T, Sillanpaa M, et al. Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia. 2005;46:54-61.
8. Cohen MJ, Meador KJ, Browning N, et al. Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav. 2011;22:240-248.
9. Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res. 1999;33:145-158.
10. Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med. 2001;344:1132-1138.
11. Fried S, Kozer E, Nulman I, et al. Malformation rates in children of women with untreated epilepsy. Drug Saf. 2004;27:197-202.
12. Holmes LB, Wyszynski DF, Baldwin EJ, et al. Increased frequency for isolated cleft palate among infants exposed to lamotrigine during pregnancy. Neurology. 2008;70:2152-2158.
13. Artama M, Auvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology. 2005;64:1874-1878.
14. Tomson T, Battino D. The management of epilepsy in pregnancy. In: Shorvon S, Pedley TA, eds. Blue Books of Neurology Series: The Epilepsies 3. Vol 33. Philadelphia, PA: Elsevier Saunders; 2008.
15. Pennell PB. Pregnancy in women who have epilepsy. Neurol Clin. 2004;22:799-820.
16. Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73:133-141.
17. Morrow J, Russell A, Guthrie E, et al. Malformations risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 2006;77:193-198.
18. Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr. 2004;93:174-176.
19. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2004;75: 1575-1583.
20. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology. 2004;62: 28-32.
21. Almgren M, Kallen B, Lavebratt C. Populationbased study of antiepileptic drug exposure in utero-influence on head circumference in newborns. Seizure. 2009;18:672-675.
22. Wlodarczyk BJ, Palacios AM, George TM, et al. Antiepileptic drugs and pregnancy outcomes. Am J Med Genet A. 2012;158A:2071-2090.
23. Puho EH, Szunyogh M, Metneki J, et al. Drug treatment during pregnancy and isolated orofacial clefts in Hungary. Cleft Palate Craniofac J. 2007;44:194-202.
24. Scolnik D, Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA. 1994;271:767-770.
25. Vajda FJ, Graham J, Roten A, et al. Teratogenicity of the newer antiepileptic drugs-the Australian experience. J Clin Neurosci. 2012;19:57-59.
26. Mawer G, Briggs M, Baker GA, et al. Liverpool& Manchester Neurodevelopment Group. Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure. 2010;19: 112-119.
27. Katz O, Levy A, Wiznitzer A, et al. Pregnancy and perinatal outcome in epileptic women: a population- based study. J Matern Fetal Neonatal Med. 2006;19:21-25.
28. Borthen I, Eide MG, Veiby G, et al. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG. 2009;116: 1736-1742.
29. Borthen I, Eide M, Daltveit A, et al. Obstetric outcome in women with epilepsy: a hospitalbased, retrospective study. BJOG. 2011;118: 956-965.
30. Viinikainen K, Heinonen S, Eriksson K, et al. prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia. 2006;47:186-192.
31. Hvas CL. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG. 2000;107:896-902.
32. American College of Obstetricians and Gynecologists. Seizure Disorders in Pregnancy. ACOG Educational Bulletin #241.Washington, DC, 1996.
33. National Institute for Clinical Excellence. Epilepsies, the diagnosis andmanagement of the epilepsies in adults and children in primary and secondary care. Clinical Guideline; Vol 20. London: National Institute for Clinical Excellence; 2004: 19-20.
34. Bauer J, Bos M, Ruck J, et al. Evaluation of folate substitution in women with epilepsy. Determination of erythrocyte folic acid concentrations. Nervenarzt. 2011;82:459-461.
35. Wilson RD, Johnson JA, Wyatt P, et al. Preconceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can. 2007;29:1003-1026.
36. Harden CL, Sethi NK. Epileptic disorders in pregnancy: an overview. Curr Opin Obstet Gynecol. 2008;20:557-562.
37. Harden CL, Pennell PB, Koppel BS, et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73: 142-149.
38. Vajda FJE, Hitchcock A, Graham J, et al. Seizure control in antiepileptic drug treated pregnancy. Epilepsia. 2008;49:172-175.
39. Thomas SV, Syam U, Devi JS. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia. 2012;53:e85-e88.
40. Teramo K, Hiilesmaa V, Bardy A, et al. Fetal heart rate during a maternal grand mal epileptic seizure. J Perinatal Med. 1979;7:3-6.
41. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Neurology. 1998;51:944-948.
42. World Health Organization. Medical Eligibility Criteria for Contraceptive Use. 4th ed. Geneva, Switzerland: World Health Organization; 2009: 1-125.
43. Fairgrieve SD, Jackson M, Jonas P, et al. Population based, prospective study of the care of women with epilepsy in pregnancy. BMJ. 2000;321:674-675.
44. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and agespecific fertility rates of women with epilepsy. Lancet. 1998;352:1970-1973.
45. Annegers J, Hauser W, Elveback L, et al. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol. 1978;7:241-247.
46. Berkovic SR, Howell RA, Hay DA, et al. Epilepsies in twins: genetics of et al major epilepsy syndromes. Ann Neurol. 1998;43:435-445.
47. Friis B, Sardemann H. Neonatal hypocalcaemia after intrauterine exposure to anticonvulsant drugs. Arch Dis Child. 1977;52:239-247.